ChinaBio Partnering Forum 2016
This is a must-attend session for those who wish to expand their capabilities not only to evaluate prospective financial and strategic partners, but to develop and execute partnership arrangements with such partners. Frank Yu and Bin Li, the Founder/CEO and CIO of Ally Bridge Group, will share insights on how Ally Bridge Group transformed itself from a boutique healthcare investment firm into a heavyweight global healthcare investor that spearheaded and completed the US$3.3B take-private of WuXi PharmaTech. Among other things, Mr. Yu and Mr. Li will share case studies of how they built a partnership/portfolio network that spans Asia, North America and Europe, were able to deploy their funds through a variety of investment structures (PE/VC, PIPEs, takeovers, hedge fund) and, ultimately create accretive partnership opportunities and exits for both their portfolio companies and strategic investors. Thomas Chou and Janet Xiao, partners at Morrison & Foerster LLP who advise Ally Bridge on the corporate and IP aspects of its investments, will also participate in this session.